Page last updated: 2024-10-16

butyric acid and Acute Confusional Senile Dementia

butyric acid has been researched along with Acute Confusional Senile Dementia in 8 studies

Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Current strategies for the treatment of Alzheimer's disease (AD) focus on the pathology in the later stages of disease progression."1.62Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. ( Jiang, Y; Li, K; Li, X; Xu, L; Yang, Z, 2021)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's6 (75.00)2.80

Authors

AuthorsStudies
Wang, C1
Zheng, D1
Weng, F1
Jin, Y2
He, L1
Yuan, B1
Liu, M1
Gong, Y1
Wang, Z1
Jin, X1
Xie, G1
Zhu, M1
Zhang, X1
Luo, S1
Qu, Q1
Zhu, Y1
Wang, M1
Li, B2
Wang, W1
Gao, C1
He, Y1
Huang, P1
Du, J1
He, G1
Zhang, P1
Tang, H1
Chen, S1
Fernando, WMADB1
Martins, IJ1
Morici, M1
Bharadwaj, P1
Rainey-Smith, SR1
Lim, WLF1
Martins, RN1
Kim, SY1
Chae, CW1
Lee, HJ1
Jung, YH1
Choi, GE1
Kim, JS1
Lim, JR1
Lee, JE1
Cho, JH1
Park, H1
Park, C1
Han, HJ1
Jiang, Y1
Li, K1
Li, X1
Xu, L1
Yang, Z1
Tran, TTT1
Corsini, S1
Kellingray, L1
Hegarty, C1
Le Gall, G1
Narbad, A1
Müller, M1
Tejera, N1
O'Toole, PW1
Minihane, AM1
Vauzour, D1
Cuadrado-Tejedor, M1
Ricobaraza, AL1
Torrijo, R1
Franco, R1
Garcia-Osta, A1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
DIetary plAnt Extracts, Colonic MicrObes, and Apoe geNetics Interactions stuDy[NCT05905822]64 participants (Anticipated)Observational2023-06-19Recruiting
A Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS[NCT04987671]Phase 1/Phase 214 participants (Anticipated)Interventional2021-08-05Active, not recruiting
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy[NCT04937062]Early Phase 150 participants (Anticipated)Interventional2021-03-01Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for butyric acid and Acute Confusional Senile Dementia

ArticleYear
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:7

    Topics: Aged; Alzheimer Disease; Animals; Apolipoproteins E; Butyric Acid; Cognitive Dysfunction; Female; Ga

2019

Other Studies

7 other studies available for butyric acid and Acute Confusional Senile Dementia

ArticleYear
Sodium butyrate ameliorates the cognitive impairment of Alzheimer's disease by regulating the metabolism of astrocytes.
    Psychopharmacology, 2022, Volume: 239, Issue:1

    Topics: Alzheimer Disease; Animals; Astrocytes; Butyric Acid; Cognitive Dysfunction; Mice; Mice, Transgenic

2022
Sodium butyrate exerts antioxidant stress effects and attenuates Aβ
    Archives of biochemistry and biophysics, 2022, 11-30, Volume: 731

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Butyric Acid; Cell Survi

2022
Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments.
    CNS neuroscience & therapeutics, 2023, Volume: 29, Issue:11

    Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Butyric Acid; Caproates; Cognitive Dysf

2023
Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage.
    Journal of Alzheimer's disease : JAD, 2020, Volume: 74, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain Chemistry; Butyric Acid; Cues; Diet; Fear;

2020
Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1.
    Cell death & disease, 2020, 06-18, Volume: 11, Issue:6

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyric Acid; Humans; Mice; NADPH Oxidase 2; NF-E

2020
Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.
    Chemico-biological interactions, 2021, May-25, Volume: 341

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Butyric Acid; Cognitive Dysfunction; Disea

2021
Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.
    Current pharmaceutical design, 2013, Volume: 19, Issue:28

    Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biomarkers; Butyric Acid; C

2013
Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.
    Current pharmaceutical design, 2013, Volume: 19, Issue:28

    Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biomarkers; Butyric Acid; C

2013
Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.
    Current pharmaceutical design, 2013, Volume: 19, Issue:28

    Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biomarkers; Butyric Acid; C

2013
Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.
    Current pharmaceutical design, 2013, Volume: 19, Issue:28

    Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biomarkers; Butyric Acid; C

2013